Archives of Dermatological Research

, Volume 305, Issue 2, pp 173–177 | Cite as

Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura

  • Tao Chen
  • Rui-zhen Jia
  • Zai-pei GuoEmail author
  • Na Cao
  • Meng-meng Li
  • Xiao-yan Jiao
Short Communication


Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis and is known as an immunoglobulin (Ig) A related immune complex-mediated disease. However, the molecular mechanisms in the development of HSP are not yet fully understood. Herein, we investigated the serum levels of Interleukin (IL)-33 and soluble ST2 (sST2) in HSP patients and their association with disease severity and IgA autoantibodies production. The serum levels of IL-33 and sST2 were measured by double antibody sandwich enzyme-linked immunosorbent assay (ELISA) in the serum of 33 patients with HSP and 22 controls. Serum levels of IgA anti-endothelial cell antibodies (AECA) and IgA anticardiolipin antibodies (ACA) in HSP patients were detected by double antigen sandwich ELISA. Our results indicated that serum levels of IL-33 but not sST2 were significantly elevated in patients with HSP in acute stage and restored to normal levels in convalescent stage. Moreover, serum IL-33 levels were correlated with the severity of HSP and serum concentrations of AECA-IgA and ACA-IgA. Taken together, we show firstly that serum IL-33 is abnormally elevated in HSP patients. IL-33 might be associated with the IgA autoantibodies production in the pathogenesis of HSP.


Henoch-Schonlein purpura Interleukin-33 Soluble ST2 Anti-endothelial cell antibodies IgA Anticardiolipin antibodies IgA 



This study was supported with grants from Natural Science Foundation of China (81101198).


  1. 1.
    Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051–2054PubMedGoogle Scholar
  2. 2.
    Chen T, Guo ZP, Zhang YH, Gao Y, Liu HJ, Li JY (2011) Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura. Rheumatol Int 31:321–326PubMedCrossRefGoogle Scholar
  3. 3.
    Choi YS, Choi HJ, Min JK, Pyun BJ, Maeng YS, Park H (2009) Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 114:3117–3126PubMedCrossRefGoogle Scholar
  4. 4.
    Demyanets S, Konya V, Kastl SP, Kaun C, Rauscher S, Niessner A et al (2011) Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 31:2080–2089PubMedCrossRefGoogle Scholar
  5. 5.
    Kawakami T, Watabe H, Mizoguchi M, Soma Y (2006) Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol 155:983–987PubMedCrossRefGoogle Scholar
  6. 6.
    Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103–110PubMedCrossRefGoogle Scholar
  7. 7.
    Linskey KR, Kroshinsky D, Mihm MC Jr, Hoang MP (2012) Immunoglobulin-A-associated small vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol 66:813–822PubMedCrossRefGoogle Scholar
  8. 8.
    Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T (2009) Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 386:181–185PubMedCrossRefGoogle Scholar
  9. 9.
    Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The american college of rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114–1121PubMedCrossRefGoogle Scholar
  10. 10.
    Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:216–225PubMedCrossRefGoogle Scholar
  11. 11.
    Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS One 3:e3331PubMedCrossRefGoogle Scholar
  12. 12.
    Mu R, Huang HQ, Li YH, Li C, Ye H, Li ZG (2010) Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 37:2006–2013PubMedCrossRefGoogle Scholar
  13. 13.
    Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S et al (2009) Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60:738–749PubMedCrossRefGoogle Scholar
  14. 14.
    Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ et al (2009) Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183:5094–5103PubMedCrossRefGoogle Scholar
  15. 15.
    Pushparaj PN, Tay HK, H’ng SC, Pitman N, Xu D, McKenzie A et al (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106:9773–9778PubMedCrossRefGoogle Scholar
  16. 16.
    Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490PubMedCrossRefGoogle Scholar
  17. 17.
    Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL (2004) Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann Rheum Dis 63:1511–1513PubMedCrossRefGoogle Scholar
  18. 18.
    Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL (2002) The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-α treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol 130:352–357PubMedCrossRefGoogle Scholar
  19. 19.
    Yang Z, Liang Y, Xi W, Li C, Zhong R (2011) Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med 11:75–80PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Tao Chen
    • 1
  • Rui-zhen Jia
    • 2
  • Zai-pei Guo
    • 1
    Email author
  • Na Cao
    • 1
  • Meng-meng Li
    • 1
  • Xiao-yan Jiao
    • 1
  1. 1.Department of DermatovenereologyWest China Hospital of Sichuan UniversityChengduChina
  2. 2.Open LaboratoryWest China Second Hospital of Sichuan UniversityChengduChina

Personalised recommendations